Detalhe da pesquisa
1.
Delphi consensus on stereotactic ablative radiotherapy for oligometastatic and oligoprogressive renal cell carcinoma-a European Society for Radiotherapy and Oncology study endorsed by the European Association of Urology.
Lancet Oncol
; 25(5): e193-e204, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38697165
2.
Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: systematic review and consensus recommendations by the EORTC-ESTRO OligoCare consortium.
Lancet Oncol
; 24(3): e121-e132, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36858728
3.
Stereotactic body radiation therapy after radical prostatectomy: current status and future directions.
World J Urol
; 41(11): 3333-3344, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-37725131
4.
Accuracy and reliability of a commercial treatment planning system in nontarget regions in modern prostate radiotherapy.
J Appl Clin Med Phys
; 24(8): e14003, 2023 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-37170654
5.
Genomic biomarkers to guide precision radiotherapy in prostate cancer.
Prostate
; 82 Suppl 1: S73-S85, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35657158
6.
Multicentre, prospective study on local treatment of metastatic prostate cancer (LoMP study).
BJU Int
; 129(6): 699-707, 2022 06.
Artigo
Inglês
| MEDLINE | ID: mdl-34289231
7.
Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS): study protocol for a phase 2, open-label, randomized controlled trial.
BMC Cancer
; 21(1): 514, 2021 May 07.
Artigo
Inglês
| MEDLINE | ID: mdl-33962592
8.
Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscle-invasive bladder cancer (EFFORT-MIBC): a phase II prospective trial.
BMC Cancer
; 21(1): 1113, 2021 Oct 18.
Artigo
Inglês
| MEDLINE | ID: mdl-34663254
9.
Clinical perspectives from ongoing trials in oligometastatic or oligorecurrent prostate cancer: an analysis of clinical trials registries.
World J Urol
; 39(2): 317-326, 2021 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-31955223
10.
Exercise prescription dose for castrate-resistant prostate cancer patients: a phase I prescription dose escalation trial.
World J Urol
; 39(2): 357-364, 2021 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-32008114
11.
A modified Delphi study to develop a practical guide for selecting patients with prostate cancer for active surveillance.
BMC Urol
; 21(1): 18, 2021 Feb 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33541309
12.
Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation.
Lancet Oncol
; 21(1): e18-e28, 2020 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31908301
13.
Effect of Extended Pelvic Lymph Node Dissection on Oncologic Outcomes in Patients with D'Amico Intermediate and High Risk Prostate Cancer Treated with Radical Prostatectomy: A Multi-Institutional Study.
J Urol
; 203(2): 338-343, 2020 02.
Artigo
Inglês
| MEDLINE | ID: mdl-31437119
14.
Correction to: Metastasectomy for visceral and skeletal oligorecurrent prostate cancer.
World J Urol
; 38(6): 1589, 2020 06.
Artigo
Inglês
| MEDLINE | ID: mdl-32221712
15.
Radiotherapy treatment volumes for oligorecurrent nodal prostate cancer: a systematic review.
Acta Oncol
; 59(10): 1224-1234, 2020 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-32536241
16.
Phase II open-label study investigating apalutamide in patients with biochemical progression after radical prostatectomy.
Future Oncol
; 16(16): 1083-1189, 2020 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-32356465
17.
Health-related quality of life overview after different curative treatment options in muscle-invasive bladder cancer: an umbrella review.
Qual Life Res
; 29(11): 2887-2910, 2020 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-32504291
18.
Hyperbaric oxygen therapy for radiation cystitis after pelvic radiotherapy: Systematic review of the recent literature.
Int J Urol
; 27(2): 98-107, 2020 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-31617263
19.
Immune checkpoint blockade for organ transplant patients with advanced cancer: how far can we go?
Curr Opin Oncol
; 31(2): 54-64, 2019 03.
Artigo
Inglês
| MEDLINE | ID: mdl-30694841
20.
Patient- versus physician-reported outcomes in prostate cancer patients receiving hypofractionated radiotherapy within a randomized controlled trial.
Strahlenther Onkol
; 195(5): 393-401, 2019 May.
Artigo
Inglês
| MEDLINE | ID: mdl-30406289